WeVote

Bill

Bill

HB 5569

AN ACT RESTRICTING SALES OF NITROUS OXIDE TO LICENSED HEALTH CARE PROVIDERS AND REGULATED INDUSTRIAL ENTITIES.

2025 Regular Session Introduced by Kevin Brown and 1 co-sponsor

Connecticut bill restricts nitrous oxide sales exclusively to licensed healthcare providers and regulated industrial entities to combat recreational abuse and associated health risks.

REF. TO JOINT COMM. ON General Law
0
WeVote Research Nonpartisan
Bill Summary · HB 5569

Legislative bill overview

HB 5569 would restrict the sale and distribution of nitrous oxide (laughing gas) in Connecticut to only licensed healthcare providers and regulated industrial entities. This represents a significant tightening of current regulations by eliminating or heavily restricting commercial retail sales of nitrous oxide to the general public.

Why is this important

Nitrous oxide has become a substance of abuse, particularly among young people, who inhale it from pressurized cartridges for recreational purposes. This can cause serious health consequences including vitamin B12 depletion, nerve damage, and impaired motor control. The restriction aims to reduce accessibility and abuse while maintaining legitimate medical and industrial uses.

Potential points of contention

  • Economic impact on legitimate retailers: Businesses currently selling nitrous oxide for culinary purposes (whipped cream dispensers) or other legal applications would face significant operational disruptions or closure
  • Enforcement challenges: Defining and monitoring "licensed healthcare providers and regulated industrial entities" requires clear regulatory definitions, and black market sales could circumvent restrictions
  • Consumer freedom concerns: Some argue restrictions on adult access to a substance used in legitimate applications may constitute overreach, though public health advocates counter this with abuse prevention rationale

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.